Congenital Disease Risk Management

Congenital Disease Risk Management

Is a specialized form of genetic testing that examines an individual’s DNA to identify inherited genetic variations associated with congenital conditions or disorders present at birth. Our testing can detect a wide range of congenital conditions, including but not limited to,

  • Down Syndrome
  • Cystic Fibrosis
  • Barth Syndrome
  • Cohen Syndrome
  • Various Metabolic Disorders.
  • Congenital Disease Risk Management

    The test is valuable for individuals without a known family history of genetic conditions. Many congenital conditions can occur without a family history, making genetic testing an important tool to understand individual genetic risks.

    Congenital genetic health testing can benefit individuals planning to start a family, pregnant women, newborns, or anyone seeking to understand their risk of passing on genetic conditions to their children or future generations.

    The test process is non-invasive. It involves collecting a small saliva sample using our at-home saliva collection kit, making it a comfortable and convenient option for individuals of all ages. Our testing utilizes advanced genetic analysis techniques and technologies, providing highly accurate results. However, it’s essential to understand that no test can guarantee 100% accuracy, and the interpretation of results should be discussed with your patients.

    While the test results provide valuable genetic information, they should not be used as the sole basis for medical decision-making. It’s important to discuss test results with your patients and provide guidance and interpretation based on the individual's full medical history and circumstances.

    Disease Risk Testing

    Disease risk testing is a specialized form of genetic testing that examines an individual’s DNA to identify genetic variations and risks associated with specific diseases.

    Our Testing Reports On 14 Diseases, Including Alzheimer’s, Autism, Male Pattern Baldness, and Stroke.

    We measure the genotype index for each Rapid Stan Identification Series (or RSid) analyzed for particular disease risk. Each RSid outcome is then compared to published peer-reviewed papers to determine if the outcome indicates a higher risk of a particular disease. All the outcomes for a particular disease are then combined to provide an overall risk score.

    Disease risk testing can benefit individuals concerned about a particular disease or issue and enable mitigating care pathways to be implemented to reduce the chances of developing the disease.

    The test process is non-invasive. It involves collecting a small saliva sample using our at-home saliva collection kit, making it a comfortable and convenient option for individuals of all ages. Our testing utilizes advanced genetic analysis techniques and technologies, providing highly accurate results. However, it’s essential to understand that no test can guarantee 100% accuracy, and the interpretation of results should be discussed with patients.

    Harness the Power of Epigenetics for a Lifetime of Wellness.

    Harness the Power of Epigenetics for a Lifetime of Wellness.
    Scroll to Top